We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+6.48%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$2.3B
AUM Growth
+$225M
Cap. Flow
+$94.2M
Cap. Flow %
4.09%
Top 10 Hldgs %
40.24%
Holding
305
New
26
Increased
135
Reduced
93
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 10.28%
2 Healthcare 7.77%
3 Financials 4.92%
4 Industrials 4.71%
5 Communication Services 3.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHKP icon
201
Check Point Software Technologies
CHKP
$12.9B
$490K 0.02%
4,216
ALE
202
DELISTED
Allete
ALE
$481K 0.02%
6,867
-345
-5% -$24K
MRNS
203
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$474K 0.02%
26,431
+2,606
+11% +$41.9K
BSX icon
204
Boston Scientific
BSX
$66.9B
$443K 0.02%
10,365
-495
-5% -$20.8K
PM icon
205
Philip Morris
PM
$300B
$439K 0.02%
4,432
+2
+0% +$192
PTON icon
206
Peloton Interactive
PTON
$2.74B
$435K 0.02%
3,507
FLOT icon
207
iShares Floating Rate Bond ETF
FLOT
$10.2B
$429K 0.02%
8,447
IHF icon
208
iShares US Healthcare Providers ETF
IHF
$1.21B
$429K 0.02%
8,050
FBIN icon
209
Fortune Brands Innovations
FBIN
$5.78B
$417K 0.02%
4,891
-253
-5% -$22.1K
WBD icon
210
Warner Bros
WBD
$64.1B
$412K 0.02%
13,420
-247
-2% -$8.57K
IBB icon
211
iShares Biotechnology ETF
IBB
$9.3B
$408K 0.02%
2,495
+35
+1% +$5.39K
SAM icon
212
Boston Beer
SAM
$1.9B
$407K 0.02%
399
FLNA
213
Filana Therapeutics
FLNA
$48.3M
$401K 0.02%
+4,692
New +$251K
SLV icon
214
iShares Silver Trust
SLV
$27.8B
$401K 0.02%
16,544
+3,935
+31% +$97.5K
AMP icon
215
Ameriprise Financial
AMP
$48.3B
$398K 0.02%
1,598
LNC icon
216
Lincoln National
LNC
$8.66B
$391K 0.02%
6,228
GPC icon
217
Genuine Parts
GPC
$17.2B
$390K 0.02%
3,084
AMD icon
218
Advanced Micro Devices
AMD
$797B
$389K 0.02%
+4,144
New +$335K
MO icon
219
Altria Group
MO
$116B
$387K 0.02%
8,097
+58
+0.7% +$2.85K
SCZ icon
220
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.3B
$386K 0.02%
5,200
-30
-0.6% -$2.25K
ARKK icon
221
ARK Innovation ETF
ARKK
$5.57B
$383K 0.02%
2,930
+127
+5% +$14.8K
MUSA icon
222
Murphy USA
MUSA
$11.3B
$370K 0.02%
2,774
XLU icon
223
State Street Utilities Select Sector SPDR ETF
XLU
$22.9B
$356K 0.02%
11,252
MCHP icon
224
Microchip Technology
MCHP
$40.6B
$353K 0.02%
4,716
-84
-2% -$6.4K
GWX icon
225
State Street SPDR S&P International Small Cap ETF
GWX
$859M
$352K 0.02%
9,116

Similar funds

Grimes & Company's Q2 2021 Portfolio in Review

As of Q2 2021, Grimes & Company held 305 positions worth $2.3B, up 11% from $2.08B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Grimes & Company deployed $94.2M of net new capital in Q2 2021, opening 26 new positions and adding to 135 existing holdings. Its largest new stake was Invesco Ultra Short Duration ETF: 38,101 shares worth $1.92M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Expeditors International, an estimated $10.4M trimmed.

  • Grimes & Company's largest Q2 2021 buy was Invesco Ultra Short Duration ETF: 38,101 shares worth $1.92M.
  • Grimes & Company added most to State Street Technology Select Sector SPDR ETF in Q2 2021, an estimated $14.7M increase.
  • Grimes & Company's biggest Q2 2021 reduction was Expeditors International, cutting an estimated $10.4M.
  • Grimes & Company fully exited FLIR Systems, Inc. (DE) Common Stock in Q2 2021, selling an estimated $10.4M.
  • Grimes & Company's ten largest holdings make up 40% of its $2.3B portfolio in Q2 2021.
  • Grimes & Company opened 26 new positions and closed 3 in Q2 2021.
  • Grimes & Company's portfolio value rose 11% quarter-over-quarter to $2.3B.

Based on Grimes & Company's 13F filing for Q2 2021, filed 4 Aug 2021.